News

AUGA Group Reveals Audited Financial Results and Future Plans

AUGA Group Reveals Audited Financial Results and Future Plans

AUGA Group's Financial Results for 2024

AUGA Group, with code 126264360, located at Konstitucijos pr. 21C, Vilnius, has shared its consolidated and separate financial statements, along with a comprehensive management report and independent auditor's opinion for the year ending December 31, 2024.

Insights into Revenue and Losses

The audited revenue for AUGA Group and its subsidiaries for 2024 reached EUR 85.4 million, a notable increase from EUR 77.4 million in 2023. However, the Group faced significant financial hurdles, reporting an audited net loss of EUR 32.4 million, surpassing the previously announced unaudited loss of EUR 26.9 million.

Understanding the Qualified Opinion

The independent auditors provided a qualified opinion indicating substantial uncertainty regarding the Company’s ability to continue operations as a going concern. This concern stems from restructuring measures that the Company and several of its subsidiaries were compelled to initiate amid an exceedingly challenging financial landscape.

Challenges and Strategic Responses

The year 2024 proved to be especially difficult for the Group. Management engaged in extensive efforts to refinance bonds nearing maturity and to extend financing agreements but ultimately fell short, leading to restructuring processes.

Despite these barriers, the AUGA Group team made strategic moves towards the 2025 harvest season, focusing on enhancing dairy farm productivity and maintaining robust relationships with partners and customers while re-evaluating the benefits of its operational structure.

Crop Segment Losses

One of the most significant issues arose within the crop segment, which recorded a loss of EUR 10.48 million. This setback was attributed to rampant production costs, declining prices from prior years, and unfavorable weather conditions impacting legume cultivation. The Group was also compelled to sell a large portion of the harvest in the fall when prices were typically lower, further exacerbating the financial issues.

Financial Comparison: Audited vs. Unaudited

Notably, a more than 10% discrepancy exists between the Group's audited financial figures and the previously released unaudited results. The net loss according to the unaudited results was EUR 26.9 million compared to the audited loss of EUR 32.4 million, representing a difference of EUR 5.575 million.

This difference primarily arose due to an impairment of intangible assets under development, forcing the Group to pause technology expansion projects, compounding the existing uncertainties regarding future development prospects.

Revised EBITDA Forecast

On September 4, 2024, AUGA Group's management revised their EBITDA forecast to EUR 11.5 million. The reported audited EBITDA details a marginal profit of EUR 0.075 million. The primary reasons for revenue discrepancies include:

  • Lower than anticipated outcomes in crop and biomethane production sectors, with losses of EUR 10.5 million against a projected profit of EUR 2.6 million.
  • Shortfalls in gross profit expectations for the mushroom segment, clocking in at EUR 1.59 million compared to the forecasted EUR 2.2 million.
  • Higher operating costs than planned, amounting to EUR 12 million instead of the targeted EUR 10.4 million.
  • Partially offsetting these losses, the dairy segment performed better, yielding EUR 5.12 million versus a forecast of EUR 2 million.

While operating costs exceeded projections, they still remained lower compared to 2023, which faced nearly EUR 14 million in similar costs.

Contact Information

For further insights, you may contact:
Chief Financial Officer of AUGA Group under restructuring
Kristupas Baranauskas
Phone: +370 5 233 5340

Frequently Asked Questions

What are the audited results published by AUGA Group for 2024?

AUGA Group reported a revenue of EUR 85.4 million and a net loss of EUR 32.4 million for 2024, along with comprehensive financial statements.

What factors contributed to AUGA Group's significant loss in 2024?

The main factors included increased production costs, poor weather conditions affecting crop yields, and the decision to sell harvests at lower prices due to cash flow needs.

What does the qualified opinion from the auditors imply?

The qualified opinion indicates concerns about the Group's ability to continue as a going concern amid restructuring challenges and financial difficulties.

How does the audited EBITDA compare to previous forecasts?

The audited EBITDA revealed a profit of EUR 0.075 million, which deviated significantly from the initial forecasts, mainly due to underperformance in key business segments.

Who can be contacted for more information regarding the financial results?

Kristupas Baranauskas, Chief Financial Officer, is available for inquiries at +370 5 233 5340.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 20

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 314

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 23

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 13

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 328

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 12

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 286

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 287

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading

Top 5 Most Recently Viewed Articles

AAVantgarde's Professor Auricchio Receives Prestigious Role

Updated Category News Views 177

AAVantgarde's Professor Auricchio Achieves New Milestone MILAN, a milestone moment has arrived for AAVantgarde Bio as Professor Alberto Auricchio, the visionary Founder and Chief Scientific Officer, has been elected President of the European Society of Gene and Cell Therapy. This prestigious appointment recognizes his exceptional contributions and unwavering commitment to...

Continue Reading
How Bitcoin's Drop Affects Strategy Inc (NASDAQ: MSTR) Investors

Updated Category News Views 137

Understanding the Current Market Landscape As recent market trends demonstrate, Strategy Inc (NASDAQ: MSTR) is seeing significant activity. On one hand, the company is evidently reliant on the performance of Bitcoin. With such dependence, the fluctuations in the value of Bitcoin are crucial to the health of MSTR. This situation poses both risks and opportunities for...

Continue Reading
Significant Attorney Departures to Strengthen Association Law Firm

Updated Category News Views 99

Major Attorney Moves to Association Law Group (ALG) In a noteworthy shift within Florida's community association law landscape, several prominent attorneys have transitioned from Becker & Poliakoff to join the ranks of Association Law Group (ALG). Among them, Michael C. Gongora, Lilliana Farinas-Sabogal, and Adam Cervera are recognized for their extensive experience in...

Continue Reading
EQB's Commitment to Sustainability in Financial Services

Updated Category News Views 175

EQB Focuses on Sustainability in Its Latest Report EQB Inc. (TSX: EQB) has recently published a detailed Responsibility Report, highlighting significant strides towards its sustainability commitments. This annual report encapsulates the company's dedication to fostering an environment of innovation within the Canadian banking sector, with a particular focus on enriching...

Continue Reading
BofA's Downgrade of Sandvik: Navigating Market Pressures Ahead

Updated Category News Views 103

BofA Securities dropped a bomb on Sandvik AB back then by downgrading it from Neutral to Underperform. This move sent shockwaves through the trading floor, mainly because they saw some serious trouble brewing in Sandvik’s Machining and Manufacturing Solutions (SMMS) division. Traders were quick to pick up on the whispers about short cycle pressures that could really...

Continue Reading